News - Page 4 of 7 - Kheiron Medical

New results show Mia, Kheiron’s breast screening AI, could help solve the breast cancer screening workforce crisis and Covid backlog.

Today Dr Nisha Sharma and Dr Jonathan James – both NHS breast cancer radiologists and principal investigators for Kheiron Medical Technologies – presented the first internal results of the impact of Mia, Kheiron’s breast screening AI solution, on the UK’s National Health Service breast screening programme. The results were presented at the Radiological Society of…

Find out more

Addressing racial disparities in healthcare – New collaboration formed to develop AI for breast cancer screening on a racially diverse population of patients

Kheiron Medical Technologies and Emory University announced a collaboration today that will ensure African American women are included in the validation of a new AI breast screening technology. The new AI breast screening technology by Kheiron, called Mia, will evaluate data from prior mammograms on over 50,000 African American women who have been screened at Emory Healthcare. Research…

Find out more

Innovation Theatre Presentation

Listen to our co-founders talk about Mia, our AI breast screening solution

Find out more

Beating the cancer backlog is AI’s largest test yet

Telegraph article: Co-founders Peter Kecskemethy and Tobias Rijken were interviewed for this piece on how start-ups like Kheiron Medical and Skin Analytics are using their AI in the UK to detect cancer.

Find out more

Kheiron wins UK Government award to help solve critical challenges in UK breast screening with Mia

Today the UK Government announced the winners of its first Artificial Intelligence (AI) in Health and Care Awards and Kheiron’s bid was successful. The funding that’s been won will accelerate the roll out and rapid adoption of Mia (Mammography Intelligent Assessment) to address critical challenges in breast screening services in the UK. Peter Kecskemethy, co-founder and CEO of Kheiron Medical Technologies said:…

Find out more

Defying the downturn – Kheiron CEO featured

Kheiron CEO Peter Kecskemethy was interviewed for an article in the Sunday Times business section on 21 June. The piece looked at how cash is flowing into promising health and biotech start-ups despite the harsh environment due to COVID-19.

Find out more

Doctors turn to AI to clear 27-month breast cancer screening backlog

Kheiron CEO Peter Kecskemethy was interviewed for an article in the Telegraph on Saturday 20 June. The piece covered increased interest in Mia, our breast screening AI, from services who are looking for solutions to help deal with the backlog of women waiting for screening because of the COVID-19 pandemic.

Find out more

The NHSX buyers checklist for AI – how does our breast cancer screening AI, Mia, measure up?

The COVID-19 pandemic has upped the pace at which healthcare systems are adopting new technologies. It makes it even more inevitable that AI will play an increasingly important role in the healthcare challenges we face but accelerating its adoption comes with a special responsibility: patient safety must always come first so AI solutions must demonstrate…

Find out more

Supporting breast screening services post COVID-19: How can an AI solution help?

Last weekend (1 June 2020), our breast screening AI solution, Mia, was showcased by the UK Government’s BEIS Department (Department of Business, Energy and Industrial Strategy). This case study highlights the potential for AI to support breast screening services which are currently on pause because of #Covid-19, putting women’s lives at risk. We have heard…

Find out more

Kheiron Chief Strategy Officer Sarah Kerruish on BBC’s Tech Tent

Sarah talks about our breast screening AI solution Mia and how we believe it’s the power of AI + humans that will bring the most meaningful value

Find out more